(Q35193093)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

2 references

15 August 2020

Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

15 August 2020

Carlo V Caballero-Uribe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Carlos Pineda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marcia Gonclaves de Oliveira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Pedro Saul Lipszyc

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jose Julian Lopez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marcelo Mario Mataos Moreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Valderilio Feijo Azevedo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

12 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 April 2015

1 reference

15 August 2020

Clinical Rheumatology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

15 August 2020

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

635-640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

29 February 2020

copyright license

start time

12 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4365179

Biosimilars: what's in a name?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4365179

Pharmacovigilance and biosimilars: considerations, needs and challenges

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4365179

The role of biosimilars in the treatment of rheumatic diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4365179

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4365179

[Interchangeability of biological drugs: considerations about the approval of biogeneric formulations in Chile]

28 July 2018

1 reference

12 December 2020

1 reference

12 December 2020

Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases

1 reference

12 December 2020

Potential Regulatory and Commercial Environment for Biosimilars in Latin America

1 reference

12 December 2020

10.1007/S10067-015-2887-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

25673060

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25673060%20AND%20SRC:MED&resulttype=core&format=json